Empirically Establishing Blood Glucose Targets to Achieve HbA1c Goals

被引:78
作者
Wei, Nancy [1 ]
Zheng, Hui [2 ]
Nathan, David M. [1 ]
机构
[1] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Diabet, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Ctr Biostat, Boston, MA 02114 USA
关键词
CARE;
D O I
10.2337/dc13-2173
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To determine the average fasting, postprandial, and bedtime self-monitored blood glucose (SMBG) concentrations associated with specified HbA(1c) levels using data from the A1c-Derived Average Glucose (ADAG) study. RESEARCH DESIGN AND METHODS The ADAG study was a multicenter observational study that used continuous glucose monitoring and SMBG testing to determine the relationship between mean average glucose and HbA(1c). We used the SMBG data from 470 of the ADAG study participants (237 with type 1 diabetes and 147 with type 2 diabetes) to determine the average fasting, premeal, 90-min postmeal, and bedtime blood glucose (BG) for predefined target HbA(1c) groups between 5.5 and 8.5% (37-69 mmol/mol). t Tests were used to compare mean BG values between type 1 and type 2 diabetes groups. RESULTS The average fasting BG needed to achieve predefined HbA(1c) target levels of 5.5-6.49% (37-47 mmol/mol), 6.5-6.99% (48-52 mmol/mol), 7.0-7.49% (52-58 mmol/mol), 7.5-7.99% (58-64 mmol/mol), and 8.0-8.5% (64-69 mmol/mol) were 122 mg/dL with 95% CI 117-127, 142 mg/dL (135-150), 152 mg/dL (143-162), 167 mg/dL (157-177), and 178 mg/dL (164-192), respectively. Postmeal BG to achieve the HbA(1c) level of 6.5-6.99% (48-52 mmol/mol) and 7.0-7.49% (52-58 mmol/mol) were 139 mg/dL (134-144) and 152 mg/dL (147-157), respectively. Bedtime BG was 153 mg/dL (145-161) and 177 mg/dL (166-188), respectively. CONCLUSIONS We have determined the average BG at premeal, postmeal, and bedtime to achieve a variety of HbA(1c) targets. These results, based on empirical data, will help patients and providers set realistic day-to-day SMBG targets to achieve individualized HbA(1c) goals.
引用
收藏
页码:1048 / 1051
页数:4
相关论文
共 8 条
[1]  
Amer Diabet Assoc, 2011, DIABETES CARE, V34, pS11, DOI [10.2337/dc10-S062, 10.2337/dc14-S081, 10.2337/dc11-S011, 10.2337/dc13-S011, 10.2337/dc13-S067, 10.2337/dc12-s064, 10.2337/dc11-S062, 10.2337/dc10-S011, 10.2337/dc12-s011]
[2]   AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS MEDICAL GUIDELINES FOR CLINICAL PRACTICE FOR DEVELOPING A DIABETES MELLITUS COMPREHENSIVE CARE PLAN [J].
Handelsman, Yehuda ;
Mechanick, Jeffrey I. ;
Blonde, Lawrence ;
Grunberger, George ;
Bloomgarden, Zachary T. ;
Bray, George A. ;
Dagogo-Jack, Samuel ;
Davidson, Jaime A. ;
Einhorn, Daniel ;
Ganda, Om ;
Garber, Alan J. ;
Hirsch, Irl B. ;
Horton, Edward S. ;
Ismail-Beigi, Faramarz ;
Jellinger, Paul S. ;
Jones, Kenneth L. ;
Jovanovic, Lois ;
Lebovitz, Harold ;
Levy, Philip ;
Moghissi, Etie S. ;
Orzeck, Eric A. ;
Vinik, Aaron I. ;
Wyne, Kathleen L. .
ENDOCRINE PRACTICE, 2011, 17 :1-+
[3]  
IDF Clinical Guidelines Task Force, 2012, GLOB GUID TYP 2 DIAB
[4]  
International Diabetes Federation (European Region), 1998, DESKT GUID TYP 1 INS
[5]  
Nathan DM, 2008, DIABETES CARE, V31, P173, DOI [10.2337/dc08-0545, 10.2337/dc08-9016]
[6]   LONG-TERM COMPLICATIONS OF DIABETES-MELLITUS [J].
NATHAN, DM .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (23) :1676-1685
[7]  
Rydén L, 2007, EUR HEART J, V28, P88, DOI [10.1093/eurheartj/ehl260, 10.1093/eurheartj/ehm124]
[8]   STANDARDS OF CARE FOR DIABETES [J].
WEIR, GC ;
NATHAN, DM ;
SINGER, DE .
DIABETES CARE, 1994, 17 (12) :1514-1522